双单位悬臂与三单位固定-可摘树脂粘接桥修复缺失磨牙的随机对照试验
本随机对照试验比较双单位悬臂(CL2)与三单位固定-可摘(FM3)树脂粘接桥修复单个磨牙大小缺隙的短期临床性能和患者报告结局。结论认为CL2可用于磨牙大小缺隙的修复,短期并发症极少。
要点
- CL2与FM3树脂粘接桥一年成功率分别为97.1%和97.7%,无显著差异。
- 两组修复体脱粘后均可重新粘接,一年存留率均为100%。
- 患者满意度及OHIP-49评分两组无显著差异。
核心结论
- CL2树脂粘接桥可用于替代磨牙大小缺隙,一年内观察到的并发症极少。
- CL2与FM3在临床和患者报告结局方面具有可比性。
研究设计与样本
- 随机对照试验,按1:1比例分配至CL2或FM3树脂粘接桥。
- 纳入缺隙为8-10 mm磨牙大小且有12对咬合单位的受试者。
主要发现
- 一年随访时CL2和FM3各有一个修复体脱粘,成功率分别为97.1%和97.7%(P>0.05)。
- 两个脱粘修复体均重新粘接,两种设计一年存留率均为100%。
- 患者满意度问卷和OHIP-49总结评分组间无显著差异(P>0.05)。
关键数值与推荐
- 生存定义为原修复体存留,成功定义为生存且无并发症。
- 统计显著性水平α=0.05,采用t检验/Mann-Whitney U检验/Wilcoxon符号秩检验、卡方检验和log-rank检验。
临床怎么用
- CL2树脂粘接桥可作为磨牙缺失的修复选择,短期临床和患者报告结局与FM3相当。
- CL2设计更保守、操作更简单且便于患者维护,可扩大其临床应用。
局限性
- 仅报告一年短期随访数据,长期数据仍在收集。
- 多数修复体由临床经验少于2年的操作者完成。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the short-term clinical performance and patient-reported outcomes of two-unit cantilevered (CL2) and three-unit fixed-movable (FM3) RBFPDs for replacement of single molar-sized spans. MATERIALS AND METHODS: Subjects with an 8-10 mm molar-sized edentulous span(s) and 12 pairs of occluding units were randomly assigned to receive either CL2 or FM3 RBFPD (ratio 1:1). The survival (retention of original prosthesis) and success (survival, complication-free) of RBFPDs at one-year were analysed. Patient-reported outcomes were assessed by prosthesis satisfactory questionnaire and Oral Health Impact Profile (OHIP-49). Data in mean, proportion and longevity were analysed by t-test/Mann-Whitney U test/Wilcoxon signed-rank test, chi-square and log-rank tests respectively at significance level α = 0.05. TRIAL REGISTRATION: ClinicalTrials.gov Identifier NCT02239718. RESULTS: Ninety-eight RBFPDs (42 CL2 and 56 FM3) were delivered in eighty-three patients. Majority (n = 89) of the prostheses were provided by operators who have less than 2 years of clinical experience. Sixty-six patients with seventy-eight RBFPDs (35 CL2 and 43 FM3) were reviewed at one-year. One CL2 and one FM3 RBFPDs debonded, resulting in a success rate at 97.1 % and 97.7 % respectively (P > 0.05). Both RBFPDs were rebonded and the survival rate were 100 % for both designs. No significant difference in satisfactions and summary OHIP-49 scores were observed (P > 0.05). CONCLUSION: CL2 RBFPDs can be used for replacing molar-sized edentulous spans with minimal observable complications up to one-year. Longer-term data is being collected. CLINICAL SIGNIFICANCE: This clinical trial demonstrates CL2 RBFPDs have comparable clinical and patient-reported outcomes as the FM3 design. This challenges the current dogma in prosthodontics and expands the clinical use of CL2 design which is more conservative, simpler and easier for patients to maintain.
引用
- Botelho MG, Yon MJY, Mak KCK, et al. A randomised controlled trial of two-unit cantilevered or three-unit fixed-movable resin-bonded fixed partial dentures replacing missing molars. J Dent. 2020. PMID: 33152408. doi:10.1016/j.jdent.2020.103519
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。